跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VYVGART SC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VYVGART SC
Authorized
STANDARD
VYVGART SC
ARGENX BV
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
66d045dfaedb0587
Company
ARGENX BV
Type
Standard
Approval Details
Approval Id
66d045dfaedb0587
Drug Approval Canada Name
VYVGART SC
Product Name
VYVGART SC
Status
Marketed
Status Date
2026-01-20
Original Market Date
2026-01-20
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
90:28.00
Atc Original
L04AA58 EFGARTIGIMOD ALFA
Aig Number
0165001002
Company Name
ARGENX BV
Company Address
Industriepark Zwijnaarde 7 Zwijnaarde -- Belgium 9052
Company Detail Path
/organization/argenx-bv
Company Information
Pharmaceutical Company Name
ARGENX BV
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
66d045dfaedb0587
Type
Standard
Back to Health Canada Approvals